Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) has a beta value of 1.81 and has seen 1,475,541 shares traded in the recent trading session. The company, currently valued at $1.53 Billion, closed the recent trade at $46.27 per share which meant it lost -$0.3 on the day or -0.81% during that session. The ICPT stock price is -170.15% off its 52-week high price of $125 and 3.83% above the 52-week low of $44.5. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.31 Million shares traded. The 3-month trading volume is 804.59 Million shares.

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) trade information

Sporting 0.31% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Jun 24 when the ICPT stock price touched $81.96- or saw a rise of 43.88%. Year-to-date, Intercept Pharmaceuticals, Inc. shares have moved -62.88%, while the 5-day performance has seen it change -43.82%. Over the past 30 days, the shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) have changed -36.34%. Short interest in the company has seen 5.8 Million shares shorted with days to cover at 0.01.

Intercept Pharmaceuticals, Inc. (ICPT) estimates and forecasts

Figures show that Intercept Pharmaceuticals, Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -62.05% over the past 6 months, with this year growth rate of 3.76%, compared to 9.3% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -29.4% and -14.3% for the next quarter. Revenue growth from the last financial year stood is estimated to be +15.7%.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +4.4% over the past 5 years. Earnings growth for 2020 is a modest -0.2% while over the next 5 years, the company’s earnings are expected to increase by -8.89%.

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)’s Major holders

Insiders own 21.51% of the company shares, while shares held by institutions stand at 80.27% with a share float percentage of 102.27%. Investors are also buoyed by the number of investors in a company, with Intercept Pharmaceuticals, Inc. having a total of 295 institutions that hold shares in the company. The top two institutional holders are FMR, LLC with over 4.87 Million shares worth more than $306.71 Million. As of March 30, 2020, FMR, LLC held 14.79% of shares outstanding.

The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 2.34 Million shares as of March 30, 2020. The firm’s total holdings are worth over $147.64 Million and represent 7.12% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Fidelity Series Large Cap Stock Fund. As of March 30, 2020, the former fund manager holds about 2.2% shares in the company for having 724601 shares of worth $45.62 Million while later fund manager owns 699.66 Thousand shares of worth $44.05 Million as of March 30, 2020, which makes it owner of about 2.12% of company’s outstanding stock.